Kansai Nerolac Q4 Review - Short-Term Pain: Dolat Capital

Kansai Nerolac Paints Ltd. (Source: Company website)

Kansai Nerolac Q4 Review - Short-Term Pain: Dolat Capital

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Dolat Capital Report

Kansai Nerolac Paints Ltd.'s revenue grew 35.1% YoY to Rs 15.9 billion in Q4 FY21, was ahead of our estimate.

Double digit growth across segments coupled with price hikes helped the surge in revenue.

The decorative business witnessed double digit volume growth during Q4.

However, the company was not able to increase market share compared to other big players.

Gross margin contracted by 440 basis points due to steep raw material inflation and not enough price pass on during the quarter.

The company is expected to implement further price hikes to mitigate cost inflation.

Click on the attachment to read the full report:

Dolat Capital Kansai Nerolac Q4FY21 Result Update.pdf

DISCLAIMER

This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.